期刊文献+

Ⅲ期非小细胞肺癌预后因素及复发因素分析 被引量:1

Analysis of prognostic and recurrence factors in stageⅢ non-small cell lung cancer
下载PDF
导出
摘要 目的 采用回顾性分析方法,对Ⅲ期非小细胞肺癌(NSCLC)的预后因素及复发因素进行分析.方法 我院1999年1月1日-2004年12月31日期间具有明确组织学类型、未经治疗过的Ⅲ期非小细胞肺癌患者175例,经手术、放疗、化疗等治疗后,观察1年、3年、5年生存率,分析预后因素,记录复发时间,分析复发因素.结果 截止到2009年11月9日,随访率95%,仍存活或失访者按截尾计算.整组患者中位生存期20个月,1、3、5年总生存率分别为43%、15%和3%.单因素分析因素T分期、临床分期、是否放化疗结合、放射治疗中断、近期疗效和急性放射性肺炎对总生存率有统计学意义.Cox逐步回归分析表明,临床分期、急性放射性肺炎、近期疗效是影响Ⅲ期非小细胞肺癌放射治疗预后的影响因素.未发现某因素为局部复发的影响因素,临床期别是远处转移的影响因素.结论 初步研究结果表明原发肿瘤临床分期、急性放射性肺炎、近期疗效等因素对Ⅲ期非小细胞肺癌的生存率有明显影响. Objective A retrospective analysis was carried out to investigate the factors of prognostic and recurrence in stageⅢ non - small cell lung cancer. Methods From January 1,1999 to December 31,2004, 175 cases with stagem NSCLC received definitive radiotherapy and eligible for the analysis. Establishing i year, 3 - year and 5 - year survival rate as endpoints to research the prognosis of NSCLC. Results The investigation was finished at November 9,2009, with a follow - up rate of 95 %, those still alive or lost calculated by censoring. The whole group median survival time was 20 months, 1,3 and 5 year survival rates were 43%, 15% and 3% respectively. Univariate analysis identified 6 significant prognostic clinical factors including T stage, clinical stage, Chemo radiotherapy,radiotherapy interruption, short - term response, acute radiotherapy pneumonia. Cox regression showed that clinical stage, acute radiotherapy pneumonia, shoi't - term response were the independent prognostic factor of patients with stage m NSCLC. There is no independent factor associated with local recurrence, clinical stage was an independent factor of distant metastasis. Conclusion The preliminary, study results show that the clinical stage of primary tumor, acute radiotherapy pneumonia, short - term response have a significant effect on the survival rate for patients with Ⅲ NSCLC,which provides a reference for the clinical treatment.
出处 《实用肿瘤学杂志》 CAS 2010年第2期144-148,174,共6页 Practical Oncology Journal
关键词 非小细胞肺癌 放射治疗 局部复发 远处转移 NSCLC Radiotherapy Prognosis Local recurrence Distant metastasis
  • 相关文献

参考文献11

  • 1李龙芸.多科协作 规范肺癌的治疗[J].中华结核和呼吸杂志,2006,29(3):145-145. 被引量:22
  • 2白春学,贾友明,陈滚珠,主编.实用内科学[M].人民卫生出版社,2001:1593-1595.
  • 3Patz EF,J r,Rossi S,Harpole DH,et al.Correlation of tumor size and survival in patients with stage1A non-small cell lung cancer[J].Chest,2000,117(6):1568-1571.
  • 4Leif Johansson MD.Histopathologic classification of lung cancer:Relevance of cytokeratin and TTF-1[J].Diagnostic Pathology,2004,8(5):259-267.
  • 5Ignatius Ou SH,Zell JA,Ziogas A,et al.Prognostic factor for survival of stageⅠnon small cell lung cancer patients[J].Cancer,2007,110(1):1532-1541.
  • 6Keller SM,Adak S,Wagner H,et al.A randomized trial of postoperative adjuvant therapy in patients with completely resected stage Ⅱor ⅢA non-small-cell lung cancer[J].N Engl J Med,2000,343(17):1217-1222.
  • 7Sause W,Kolesar P,Taylor S,et al.Final results of phase Ⅲ trial in regionally advanced unresectable non-small cell lung cancer,Radiation Therapy Onlogy Group,Eastern Cooperative Oncology Group,and Southwest Oncology Group[J].Chest,2000,117(2):358-364.
  • 8Fletcher G.Clinical dose-response curves of human malignant epithelial tumours[J].Br J Radiol,1973,46(541):1-12.
  • 9Perez CA,Pajak TF,Rubin P.Long-term observations of the patterns of failure in patients with unresectable non-small cell carcinoma of the lung treated with definitive radiotherapy[J].Cancer,1987,59(11):1874-1881.
  • 10Bradley J,Graham MV,Winter K,et al.Toxicity and outcomes results of RTOG9311:A phase Ⅰ-Ⅱdose escalation study using three dimensional conformal radiotherapy in patients with inoperable non-small cell lung carcinoma[J].Int J Radiat Oncol Phys,2005,61(2):318-328.

二级参考文献12

  • 1Spira A,Ettinger DS.Multidisciplinary management of lung cancer.N Engl J Med,2004,350:379-392.
  • 2The International Adjuvant Lung Caner Trial Collaborative Group.Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.N Engl J Med,2004,350:351-360.
  • 3Albain KS,Swann RS,Rusch VR,et al.Phase Ⅲ study of concurrent chemotherapy and radiotherapy(CT/RT)vs CT/RT followed by surgical resection for stage ⅢA (pN2)non-small cell lung cancer (NSCLC):outcomes update of North American Intergroup 0139(RTOG9309).J Clin Oncol,2005,23(s16):624S.
  • 4Mountain CF. Revisions in international system for staging lung cancer[J]. Chest, 1997;111(6) :1710-1717
  • 5Furuse K, Fukuoka M, Kawahara M, et al. Phase Ⅲ study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage Ⅲ non- small-cell lung cancer[J]. J Clin Oncol, 1999;17(9) : 2692-2699
  • 6Reboul F, Brewer Y, Vincent P, et al. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage Ⅲ nonsmall sell lung cancer: a phrase Ⅱ study[ J]. Int J Radiat Oncol Biol Phys, 1996; 35(2) : 343-350
  • 7Akerley W, Hemdon JE Jr, Lyss AP, et al. Induction paclitaxel/ earboplatin followed by concurrent chemoradiation therapy for unresectable stage III non-small-cell lung cancer: a limited access study- CALGB 9534 [ J ]. Clin Lung Cancer, 2005 ;7 ( 1 ) : 47-53
  • 8Robert S, Pritchard EL, Stephen P, et al. Chemotherapy plus Radiotherapy Alone in the Treatment of Locally Advanced, Unresectable, Non-Small-Cell Lung Cancer: a Meta-Analysis[ J]. Annal Int Med, 2005 ;129(3) : 723-729
  • 9Furuse K,Fukuoka M,Kuba M,et al. Randomized study of vinorelbine(VRB) versus vindesine (VDS) in previously untreated stage Ⅲb-Ⅳ non-small-cell lung cancer(NSCLC) [ J ]. Ann Oncol. 1996; 7(8) :815
  • 10Katayama H, Ucoka H, Kiura H, et al. Preoprative concurrent chemotherapy with cisplatin and docctaxel in patients with locally advanced non-small-cell lung cancer [J ]. Briti Cancer, 2004;90 ( 5 ) : 979-984

共引文献26

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部